Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 80

Evaluating the safety of endocardial myocardial biopsy procedures

Official title: Clinical Study of Endocardial Myocardial Biopsy

Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT05718128 · Data updated 2026-11-12

This study is testing the safety of a heart tissue biopsy procedure for patients with heart issues like myocarditis and cardiomyopathies to see how well it works and what risks it might have.

More Heart Failure trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment100 (estimated)
SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine
Academic / other
Locations1 site (Hangzhou, Zhejiang)
StatusRecruiting
StartedJune 1, 2021
Main results expectedJune 1, 2031
Study endsJune 1, 2031
Registry record updatedMarch 28, 2023
Trial IDNCT05718128 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-80 with myocarditis, cardiomyopathy, heart failure, or cardiac tumors of unknown origin who are undergoing an endocardial myocardial biopsy.

Probably not a fit

Patients who are unable to understand the informed consent process or unwilling to participate in follow-up assessments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical study focuses on patients undergoing endocardial myocardial biopsy to assess the safety of the procedure and perform pathological examinations. It includes additional tests such as viral examinations and molecular biology assessments to confirm diagnoses related to myocarditis, cardiomyopathies, heart failure, and cardiac tumors. Patients will be monitored and followed up to gather comprehensive data on outcomes and safety.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of cardiac conditions and improve diagnostic accuracy for patients with unclear heart issues.

How similar studies have gone: While there have been studies on myocardial biopsy, this specific approach focusing on safety and comprehensive diagnostic evaluation is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with no gender restriction, age 18-80 years old, receiving endocardial myocardial biopsy in the Second Affiliated Hospital of Zhejiang University School of Medicine;
* Patients with myocarditis, cardiomyopathy, heart failure and cardiac tumor of unknown clinical cause;
* Have the ability to understand the test, can cooperate with investigators.

Exclusion Criteria:

* Unable to understand or unwilling to fill in informed consent forms or follow visitors.

Where it's running

  • 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.